Notable Labs Files for Chapter 7 Bankruptcy

Dow Jones

2024-10-15

By Stephen Nakrosis

Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate.

The company said its decision comes after considering strategic alternatives.

Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%.

Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated.

Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

October 15, 2024 06:50 ET (10:50 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2475471575"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2475471575\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2475471575?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-15 18:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2475471575","market":"other","top_or_hot":-1,"title":"Notable Labs Files for Chapter 7 Bankruptcy","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre>\n \n</pre>\n<p>\n  Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate. \n</p>\n<p>\n  The company said its decision comes after considering strategic alternatives. \n</p>\n<p>\n  Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%. \n</p>\n<p>\n  Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated. \n</p>\n<p>\n  Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 15, 2024 06:50 ET (10:50 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Notable Labs Files for Chapter 7 Bankruptcy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNotable Labs Files for Chapter 7 Bankruptcy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-10-15 18:50</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre>\n \n</pre>\n<p>\n  Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate. \n</p>\n<p>\n  The company said its decision comes after considering strategic alternatives. \n</p>\n<p>\n  Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%. \n</p>\n<p>\n  Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated. \n</p>\n<p>\n  Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 15, 2024 06:50 ET (10:50 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2475471575","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2475471575","pubTimestamp":1728989400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate.The company said its decision comes after considering strategic alternatives.Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated.Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Notable Labs根据美国破产法第7章申请破产","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NTBL":0.9},"content_text":"By Stephen Nakrosis \n\n\n \n\n\n  Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate. \n\n\n  The company said its decision comes after considering strategic alternatives. \n\n\n  Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%. \n\n\n  Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated. \n\n\n  Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date. \n\n\n \n\n\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 15, 2024 06:50 ET (10:50 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}